The cloning and expression of renalase and the preparation of its monoclonal antibody
Tóm tắt
Từ khóa
Tài liệu tham khảo
Xu J, Li G, Wang P, et al. Renalase is a novel, soluble monoamine oxidase that regulates cardiac function and blood pressure [J]. J Clin Invest, 2005, 115(5): 1275–1280.
Wang J, Qi S, Cheng W, et al. Identification, expression and tissue distribution of a renalase homologue from mouse [J]. Mol Biol Rep, 2008, 35(4): 613–620.
Xu J, Desir G V. Renalase, a new renal hormone: Its role in health and disease [J]. Curr Opin Nephrol Hypertens, 2007, 16(4): 373–378.
Ghosh S S, Gehr T W B, Sica D A, et al. Renalase regulates blood pressure in salt sensitive Dahl rats [J]. J Am Soc Nephrol, 2006, 17: 208A.
Li G, Xu J, Wang P, et al. Catecholamines regulate the activity, secretion, and synthesis of renalase [J]. Circulation, 2008, 117(10): 1277–1282.
Desir G V. Renalase deficiency in chronic kidney disease, and its contribution to hypertension and cardiovascular disease [J]. Curr Opin Nephrol Hypertens, 2008, 17(2): 181–185.
Ghosh S S, Krieg R J, Sica D A, et al. Cardiac hypertrophy in neonatal nephrectomized rats: The role of the sympathetic nervous system [J]. Pediatr Nephrol, 2009, 24(2): 367–377.
Go A S, Lo J C. Epidemiology of non-dialysisrequiring chronic kidney disease and cardiovascular disease [J]. Curr Opin Nephrol Hypertens, 2006, 15(3): 296–302.
Santos S F, Peixoto A J. Hypertension in dialysis [J]. Curr Opin Nephrol Hypertens, 2005, 14(2): 111–118.
Anavekar N S, Mcmurray J J, Velazquez E J, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction [J]. N Engl J Med, 2004, 351(13): 1285–1295.
Go A S, Chertow Gm, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization [J]. N Engl J Med, 2004, 351(13): 1296–1305.
Joles J A, Koomans H A. Causes and consequences of increased sympathetic activity in renal disease [J]. Hypertension, 2004, 43(4): 699–706.
Zoccali C, Mallamaci F, Tripepi G, et al. Norepinephrine and concentric hypertrophy in patients with end-stage renal disease [J]. Hypertension, 2002, 40(1): 41–46.
Zoccali C, Mallamaci F, Parlongo S, et al. Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease [J]. Circulation, 2002, 105(11): 1354–1359.
Hausberg M, Kosch M, Harmelink P, et al. Sympathetic nerve activity in end-stage renal disease [J]. Circulation, 2002, 106(15): 1974–1979.
Zhao Q, Fan Z, He J, et al. Renalase gene is a novel susceptibility gene for essential hypertension: A two-stage association study in northern Han Chinese population [J]. J Mol Med, 2007, 85(8): 877–885.
Luft F C. Renalase, a catecholamine-metabolizing hormone from the kidney [J]. Cell Metab, 2005, 1(6): 358–360.
Boomsma F, Tipton K F. Renalase, a catecholamine-metabolising enzyme? [J]. J Neural Transm, 2007, 114(6): 756–775.